YahooSeptember 3, 2026 at 1:00 PM NYyesterday

Summit Therapeutics Says It Is Beating Merck With Its Cancer Drug

Summit says its ivonescimab is keeping lung-cancer patients alive longer than Keytruda does. The stock is up.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Companies in This Story